Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.

Saved in:
Bibliographic Details
Title: Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.
Authors: Guerra-de-Blas PDC; The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico., Marines-Price R; Office of Advanced Practice Providers, University of Texas Southwestern Medical Center, Dallas, TX, USA., Milman O; The Bronx Veterans Medical Research Foundation Inc., James J. Peters Veteran Affairs Medical Center, Bronx, NY, USA., Deal D; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Marchand J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Linton J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Meger S; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Rule J; National Association of People with HIV, Sydney, NSW, Australia., Holland TL; Division of Infectious Diseases, Duke University, Durham, NC, USA., Kitonsa J; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda., Delph Y; Axle Informatics, North Bethesda, MD, USA.
Corporate Authors: INSIGHT OTAC, ACTIV-3 TICO, ACTIV-3 substudy VATICO, and ACTIV-3b TESICO Study Groups
Source: Journal of clinical and translational science [J Clin Transl Sci] 2024 Oct 15; Vol. 8 (1), pp. e157. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Cambridge University Press Country of Publication: England NLM ID: 101689953 Publication Model: eCollection Cited Medium: Internet ISSN: 2059-8661 (Electronic) Linking ISSN: 20598661 NLM ISO Abbreviation: J Clin Transl Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39610837
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guerra-de-Blas+PDC%22">Guerra-de-Blas PDC</searchLink>; The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Marines-Price+R%22">Marines-Price R</searchLink>; Office of Advanced Practice Providers, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Milman+O%22">Milman O</searchLink>; The Bronx Veterans Medical Research Foundation Inc., James J. Peters Veteran Affairs Medical Center, Bronx, NY, USA.<br /><searchLink fieldCode="AU" term="%22Deal+D%22">Deal D</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Marchand+J%22">Marchand J</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Linton+J%22">Linton J</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Meger+S%22">Meger S</searchLink>; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Rule+J%22">Rule J</searchLink>; National Association of People with HIV, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Holland+TL%22">Holland TL</searchLink>; Division of Infectious Diseases, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kitonsa+J%22">Kitonsa J</searchLink>; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Delph+Y%22">Delph Y</searchLink>; Axle Informatics, North Bethesda, MD, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22INSIGHT+OTAC%2C+ACTIV-3+TICO%2C+ACTIV-3+substudy+VATICO%2C+and+ACTIV-3b+TESICO+Study+Groups%22">INSIGHT OTAC, ACTIV-3 TICO, ACTIV-3 substudy VATICO, and ACTIV-3b TESICO Study Groups</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101689953%22">Journal of clinical and translational science</searchLink> [J Clin Transl Sci] 2024 Oct 15; Vol. 8 (1), pp. e157. <i>Date of Electronic Publication: </i>2024 Oct 15 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cambridge+University+Press%22">Cambridge University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101689953 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-8661 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220598661%22">20598661 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Transl Sci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39610837
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1017/cts.2024.485
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e157
    Titles:
      – TitleFull: Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guerra-de-Blas PDC
      – PersonEntity:
          Name:
            NameFull: Marines-Price R
      – PersonEntity:
          Name:
            NameFull: Milman O
      – PersonEntity:
          Name:
            NameFull: Deal D
      – PersonEntity:
          Name:
            NameFull: Marchand J
      – PersonEntity:
          Name:
            NameFull: Linton J
      – PersonEntity:
          Name:
            NameFull: Meger S
      – PersonEntity:
          Name:
            NameFull: Rule J
      – PersonEntity:
          Name:
            NameFull: Holland TL
      – PersonEntity:
          Name:
            NameFull: Kitonsa J
      – PersonEntity:
          Name:
            NameFull: Delph Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 2024 Oct 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2059-8661
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of clinical and translational science
              Type: main
ResultId 1